Cargando…
Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478612/ https://www.ncbi.nlm.nih.gov/pubmed/34462405 http://dx.doi.org/10.5045/br.2021.2021067 |
| _version_ | 1784576099774103552 |
|---|---|
| author | Nam, Chang Hyun Byun, Ja Min Shin, Dong-Yeop Hong, Junshik Kim, Inho Yoon, Sung-Soo Koh, Youngil |
| author_facet | Nam, Chang Hyun Byun, Ja Min Shin, Dong-Yeop Hong, Junshik Kim, Inho Yoon, Sung-Soo Koh, Youngil |
| author_sort | Nam, Chang Hyun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8478612 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84786122021-10-09 Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study Nam, Chang Hyun Byun, Ja Min Shin, Dong-Yeop Hong, Junshik Kim, Inho Yoon, Sung-Soo Koh, Youngil Blood Res Letters to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021-09-30 2021-09-30 /pmc/articles/PMC8478612/ /pubmed/34462405 http://dx.doi.org/10.5045/br.2021.2021067 Text en © 2021 Korean Society of Hematology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Nam, Chang Hyun Byun, Ja Min Shin, Dong-Yeop Hong, Junshik Kim, Inho Yoon, Sung-Soo Koh, Youngil Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study |
| title | Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study |
| title_full | Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study |
| title_fullStr | Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study |
| title_full_unstemmed | Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study |
| title_short | Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study |
| title_sort | romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478612/ https://www.ncbi.nlm.nih.gov/pubmed/34462405 http://dx.doi.org/10.5045/br.2021.2021067 |
| work_keys_str_mv | AT namchanghyun romiplostimplusdanazolassalvagetreatmentforeltrombopagrefractoryimmunethrombocytopeniaaretrospectivepilotstudy AT byunjamin romiplostimplusdanazolassalvagetreatmentforeltrombopagrefractoryimmunethrombocytopeniaaretrospectivepilotstudy AT shindongyeop romiplostimplusdanazolassalvagetreatmentforeltrombopagrefractoryimmunethrombocytopeniaaretrospectivepilotstudy AT hongjunshik romiplostimplusdanazolassalvagetreatmentforeltrombopagrefractoryimmunethrombocytopeniaaretrospectivepilotstudy AT kiminho romiplostimplusdanazolassalvagetreatmentforeltrombopagrefractoryimmunethrombocytopeniaaretrospectivepilotstudy AT yoonsungsoo romiplostimplusdanazolassalvagetreatmentforeltrombopagrefractoryimmunethrombocytopeniaaretrospectivepilotstudy AT kohyoungil romiplostimplusdanazolassalvagetreatmentforeltrombopagrefractoryimmunethrombocytopeniaaretrospectivepilotstudy |